AMGEN INC., Plaintiff,
v.
AMNEAL PHARMACEUTICALS LLC, et al., Defendants.
United States District Court, D. Delaware.https://leagle.com/images/logo.png
Signed July 26, 2018.
Filed July 27, 2018.
Attorney(s) appearing for the Case
Jack B. Blumenfeld, Esquire and Maryellen Noreika, Esquire of Morris, Nichols, Arsht & Tunnell LLP, Wilmington, Delaware. Counsel for Plaintiff Amgen Inc. Of Counsel: Frederick C. Millett, Esquire, and Rosanna W. Gan, Esquire of Fitzpatrick, Cella, Harper & Scinto, New York, New York, and Kathryn E. Easterling, Esquire of Fitzpatrick, Cella, Harper & Scinto, Washington, D.C.
David E. Moore, Esquire, Alan R. Silverstein, Esquire, Bindu A. Palapura, Esquire, and Stephanie O'Byrne of Potter, Anderson & Corroon, LLP, Wilmington, Delaware. Counsel for Defendants Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC. Of Counsel: Jake M. Holdreith, Esquire and Kelsey J. Thorkelson, Esquire, of Robins Kaplan LLP, Minneapolis, Minnesota, Oren D. Langer, Esquire of Robins Kaplan LLP, New York, New York.
John C. Phillips, Jr., Esquire, and David A. Bilson, Esquire, of Phillips, Goldman, McLaughlin & Hall, P.A., Wilmington, Delaware. Counsel for Defendant Piramal Healthcare UK Ltd. Of Counsel: Aaron F. Barkoff, Esquire, Alejandro Menchaca, Esquire, and Rajendra A. Chiplunkar, Esquire, of McAndrews Held & Malloy Ltd., Chicago, Illinois.
John W. Shaw, Esquire, Karen E. Keller, Esquire, and David M. Fry, Esquire, of Shaw Keller LLP, Wilmington, Delaware. Counsel for Defendants Watson Laboratories, Inc., Actavis, Inc., and Actavis Pharma, Inc. Of Counsel: Christopher B. Essig, Esquire, George C. Lombardi, Esquire, Elizabeth E. Grden, Esquire, and Zachary L. Sorman, Esquire of Winston & Strawn LLP, Chicago, Illinois.
John C. Phillips, Jr., Esquire and David A. Bilson, Esquire, of Phillips, Goldman, McLaughlin & Hall, P.A., Wilmington, Delaware. Counsel for Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. (d.b.a. Zydus Cadila). Of Counsel: William D. Hare, Esquire, and Renita S. Rathinam, Esquire, of McNeely, Hare & War LLP, Washington, D.C., and Christopher S. Casieri, Esquire of McNeely, Hare & War LLP, Princeton, New Jersey.
OPINION
GOLDBERG, M., District Judge.
I. INTRODUCTION
This is a consolidated patent infringement action arising under the Drug Price Competition and Patent Term Restoration Act of 1984, 21 U.S.C. § 355, also known as the Hatch-Waxman Act. United States Patent No. 9,375,405 (the "'405 patent") is assigned to Plaintiff Amgen...
Let's get started
Welcome to the leading source of independent legal reporting Sign on now to see your case. Or view more than 10 million decisions and orders.
Updated daily.
Uncompromising quality.
Complete, Accurate, Current.
Listed below are the cases that are cited in this Featured Case. Click the citation to see the full
text of the cited case. Citations are also linked in the body of the Featured Case.
Cited Cases
No Cases Found
Listed below are those cases in which this Featured Case is cited. Click on the case name to see the
full text of the citing case.
